Alan, a French health tech company, has successfully attracted a whopping $460 million investment from the Netherlands-based Prosus, elevating its valuation to an impressive $6.3 billion. This funding will significantly enhance Alan's growth efforts, promoting global expansion and driving innovation in AI-powered products. Additionally, the agreement grants Alan access to Prosus's Large Commerce Model, enabling improved health insurance and telehealth services in its existing markets.